Related Experiment Video
Updated: May 20, 2026

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
Published on: September 20, 2024
Enhanced Efficacy of Cefiderocol With PolyTrim Combination Therapy in a Rabbit Model of Extensively Drug-Resistant
Eric G Romanowski1, Emily K Young1, Jonathan B Mandell1
1The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Vision Institute, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.
Purpose:
The 2023 Pseudomonas aeruginosa keratitis outbreak linked to contaminated artificial tears underscored the need for new therapies against extensively drug-resistant ocular pathogens. In vitro data suggested additive or synergistic activity between the siderophore-cephalosporin cefiderocol (FDC) and either moxifloxacin (MOX) or polymyxin B sulfate (PB). Here, we tested whether combining FDC with the commercial formulations of MOX (0.5%) or PolyTrim (PT; PB 10,000 U/mL + trimethoprim 0.1%) improved in vivo outcomes.
Methods:
New Zealand White rabbits were injected intrastromally with 5000 CFU of Pseudomonas aeruginosa strain CDC1270. After 16 hours, established infections were treated every 30 minutes for 8 hours with FDC, followed 5 minutes later by MOX or PT. Additional groups received monotherapies or saline. Bacterial burden (CFU/cornea) and anterior chamber cultures were determined, and ocular inflammation was assessed.
Results:
FDC + MOX reduced bacterial burden by 2.8 log10 CFU, outperforming FDC and MOX monotherapies, although no eyes were sterilized. PT monotherapy produced a significant 3.2 log10 reduction in CFU. The FDC + PT combination yielded the most potent activity, with almost 6.9 log10 reduction and sterilization of 10 of 12 corneas. Notably, anterior chamber invasion occurred in saline and MOX groups but in none of the FDC-containing groups, and perforations were absent in all FDC and PT treatments.
Conclusions:
FDC + PT was superior to monotherapies and to FDC + MOX, achieving frequent sterilization and preventing intraocular spread and corneal perforations. These data support PT alone or in combination with FDC as promising therapeutic candidates for the treatment of XDR P. aeruginosa keratitis.
Insights
The combination of cefiderocol (FDC) with PolyTrim (PT) effectively treated Pseudomonas aeruginosa keratitis in rabbits, sterilizing corneas and preventing spread. This FDC + PT therapy shows promise for extensively drug-resistant bacterial eye infections.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Background:
- The 2023 Pseudomonas aeruginosa keratitis outbreak highlighted the urgent need for novel therapies against drug-resistant ocular pathogens.
- In vitro studies suggested cefiderocol (FDC) combined with moxifloxacin (MOX) or polymyxin B sulfate (PB) may be effective.
Purpose of the Study:
- To evaluate the in vivo efficacy of combining cefiderocol (FDC) with commercial formulations of moxifloxacin (MOX) or PolyTrim (PT) for treating Pseudomonas aeruginosa keratitis.
Main Methods:
- New Zealand White rabbits with intrastromal Pseudomonas aeruginosa infections were treated with FDC combined with MOX or PT.
- Treatments were administered every 30 minutes for 8 hours, followed by bacterial burden assessment (CFU/cornea) and anterior chamber cultures.
Main Results:
- The FDC + PT combination achieved a 6.9 log10 reduction in bacterial burden and sterilized 10 of 12 corneas, significantly outperforming monotherapies and FDC + MOX.
- FDC-containing treatments prevented anterior chamber invasion, and FDC or PT treatments prevented corneal perforations.
Conclusions:
- The combination of cefiderocol and PolyTrim (FDC + PT) demonstrated superior efficacy in treating Pseudomonas aeruginosa keratitis.
- FDC + PT is a promising therapeutic strategy for extensively drug-resistant Pseudomonas aeruginosa keratitis, offering sterilization and protection against intraocular spread and perforation.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Acute Pyelonephritis II: Diagnostic Studies and Management
Clinical Significance of Antibiotic Resistance

